Health Technology Net

European Patent Office Grants ONK Therapeutics’ Foundational Patent for CISH Knockout in NK Cells for Use in Cancer Therapies

Staff June 27, 2023

CISH gene knockout pathway in NK cells CISH gene knockout confers enhanced metabolic profile on NK cells, created with BioRender.comThe...

Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD

Staff June 27, 2023

LONDON and RALEIGH, N.C., June 27, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”)...

Smart for Life Announces Execution of Comprehensive Canadian Distribution Agreement for its Nutritional Food Products

Staff June 26, 2023

Distribution Agreement with Two Hands Corporation Expected to Significantly Expand Audience of Consumers by Adding Additional Distribution Partners and Retail...

Sorrento Announces the Full Enrollment of the Pivotal Phase 3 Trial with Olgotrelvir (OVYDSOTM) (STI-1558), a Second Generation Oral Mpro Inhibitor, as a Standalone Treatment for COVID-19

Staff June 26, 2023

The Phase 3 study of Ovydso was initiated in China in February 2023 and enrolled and dosed 1,200 COVID-19 patients...

Amedisys and Optum to Combine, Advancing Value-Based Care for Patients

Staff June 26, 2023

BATON ROUGE, La., June 26, 2023 (GLOBE NEWSWIRE) -- Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and...

Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder

Staff June 26, 2023

Promissory note extends cash runway into early Q3 2023 OLPRUVA™ expected to be available by prescription in the U.S. beginning...

Cerevance Announces Presentation at the Gordon Research Conference: Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases

Staff June 26, 2023

BOSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel...

Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

Staff June 26, 2023

VANCOUVER, British Columbia, June 26, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional...

Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes

Staff June 26, 2023

CAMBRIDGE, Mass., June 26, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed...

Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society Symposium

Staff June 26, 2023

ART12.11, a novel and patented cocrystal of CBD reverses the impact of chronic stress on outcomes of anxiety, depression, sociability and...

ORIC Pharmaceuticals Announces $85 Million Private Placement Financing

Staff June 26, 2023

Financing led by Nextech and includes participation from EcoR1 Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, and Boxer Capital...

ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth

Staff June 26, 2023

FREMONT, CA, June 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company...

Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices

Staff June 26, 2023

IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the...

Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes

Staff June 26, 2023

MINNEAPOLIS, June 26, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics...

Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members

Staff June 26, 2023

Twirla (levonorgestrel and ethinyl estradiol) transdermal system will be made available nationwide to members of MMCAP Infuse, effective July 1,...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces U.S. Patent Issued for Bispecific Cancer Immunotherapy Treatment With Demonstrated Killing of Tumor Cells in Lung Cancer, Brain Cancer (Glioblastoma), and Metastatic Melanoma.

Staff June 26, 2023

Patent broadens protection around Ocean Biomedical’s first-in-class anti-CHi3L1 antibody to include new bispecific approaches targeting immune checkpoints, with potential application...

BioVie Presents Data Highlighting Role of Insulin Resistance and Neuroinflammation in the Development of Mild to Moderate in Alzheimer’s Disease

Staff June 26, 2023

Baseline Data from Phase 3 Trial of NE3107 Presented as Poster at the American Diabetes Association Annual MeetingCARSON CITY, Nev.,...

Health Technology Net

Did You Know?

The Case for Cardiovascular Collaboration: Why Platform Partnerships Drive Greater Practice Impact

Yonsei University Researchers Develop Deep Learning Model for Microsatellite Instability-High Tumor Prediction

AI Technology Could Dramatically Lower Lung Cancer Mortality Rates

The Relationship Between CMS Star Ratings and Financial Improvement

The Future of Ultrasound Reporting

Editor’s Picks

Being a Practice Owner Doesn’t Mean Skipping Holidays—Here’s How You Can Prepare

$35 Insulin: How The Program Came To Be, Who Did It And How Can You Use It?

Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01

LivaNova to Present at J.P. Morgan Healthcare Conference in January

LivaNova to Present at J.P. Morgan Healthcare Conference in January

AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026

AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026

European Patent Office Grants ONK Therapeutics’ Foundational Patent for CISH Knockout in NK Cells for Use in Cancer Therapies

Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD

Smart for Life Announces Execution of Comprehensive Canadian Distribution Agreement for its Nutritional Food Products

Sorrento Announces the Full Enrollment of the Pivotal Phase 3 Trial with Olgotrelvir (OVYDSOTM) (STI-1558), a Second Generation Oral Mpro Inhibitor, as a Standalone Treatment for COVID-19

Amedisys and Optum to Combine, Advancing Value-Based Care for Patients

Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder

Cerevance Announces Presentation at the Gordon Research Conference: Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases

Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes

Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society Symposium

ORIC Pharmaceuticals Announces $85 Million Private Placement Financing

ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth

Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices

Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes

Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces U.S. Patent Issued for Bispecific Cancer Immunotherapy Treatment With Demonstrated Killing of Tumor Cells in Lung Cancer, Brain Cancer (Glioblastoma), and Metastatic Melanoma.

BioVie Presents Data Highlighting Role of Insulin Resistance and Neuroinflammation in the Development of Mild to Moderate in Alzheimer’s Disease

BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index

Ovid Therapeutics Added to Russell 3000® Index

Eyenovia Announces Addition to Russell 2000® and Russell 3000® Indexes

Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01

LivaNova to Present at J.P. Morgan Healthcare Conference in January

LivaNova to Present at J.P. Morgan Healthcare Conference in January

AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026

AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026

Did You Know?

Editor’s Picks

Latest News

Fresh Off The press

You may have missed